Company Info
Phone(617) 349-1971
Year Established
2008
Ticker
CATB
Exchange
NASDAQ
Contacts
Andrew A. KomjathyCCO
Jill Milne
Co-Founder & CEO
Noah Clauser
CFO
Andrea Matthews
CBO
Chris Morabito, MD
CMO
Company Description
Astria Therapeutics, formerly Catabasis, lead program, STAR-0215, is in preclinical development to treat Hereditary Angioedema, a rare genetic disorder.
